Breaking News Instant updates and real-time market news.

AFL

Aflac

$46.70

0.07 (0.15%)

, AGNC

AGNC Investment

$18.80

-0.28 (-1.47%)

04:55
08/08/18
08/08
04:55
08/08/18
04:55

UBS to hold a conference

Financial Services Conference will be held in Chicago on August 7-8.

AFL

Aflac

$46.70

0.07 (0.15%)

AGNC

AGNC Investment

$18.80

-0.28 (-1.47%)

ALL

Allstate

$98.78

0.38 (0.39%)

APO

Apollo Global

$35.97

0.715 (2.03%)

BLK

BlackRock

$487.42

4.42 (0.92%)

BBT

BB&T

$51.72

0.29 (0.56%)

BK

BNY Mellon

$52.95

-0.09 (-0.17%)

BAC

Bank of America

$31.52

0.005 (0.02%)

AXS

Axis Capital

$54.48

-0.38 (-0.69%)

BX

Blackstone

$35.56

0.28 (0.79%)

CG

Carlyle Group

$23.90

(0.00%)

C

Citi

$72.42

0.01 (0.01%)

ETFC

E-Trade

$61.08

0.68 (1.13%)

JPM

JPMorgan

$117.54

0.44 (0.38%)

MC

Moelis

$59.20

-0.6 (-1.00%)

ICE

IntercontinentalExchange

$73.71

1.14 (1.57%)

GS

Goldman Sachs

$237.81

1.93 (0.82%)

PRU

Prudential

$100.35

0.7 (0.70%)

TRV

Travelers

$129.94

-0.07 (-0.05%)

USB

U.S. Bancorp

$53.30

0.38 (0.72%)

WFC

Wells Fargo

$58.83

-0.05 (-0.08%)

WTFC

Wintrust Financial

$89.14

-0.13 (-0.15%)

  • 09

    Aug

  • 09

    Aug

  • 16

    Aug

  • 20

    Aug

  • 24

    Sep

  • 12

    Oct

  • 14

    Jan

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 15

    Oct

  • 15

    Oct

AFL Aflac
$46.70

0.07 (0.15%)

08/01/18
08/01/18
UPGRADE
Target $52

Buy
Aflac upgraded to Buy on better fundamentals at Sandler ONeill
As previously reported, Sandler ONeill analyst John Barnidge upgraded Aflac to Buy from Hold citing its better fundamentals, as he believes its Q2 report demonstrated that there is pent up demand for its products and that the company "appears to have finally cracked" distribution of its products in the U.S. While the company is often comped as a life insurer, in many ways it is not, said Barnidge, who views the stock's valuation as attractive. He raised his price target on Aflac shares to $52 from $50.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
04/26/18
JPMS
04/26/18
NO CHANGE
Target $47
JPMS
Overweight
Aflac shares less attractive following recent rally, says JPMorgan
Aflac's earnings beat expectations in Q1, but business trends were weaker than anticipated, JPMorgan analyst Jimmy Bhullar tells investors in a post-earnings research note. He believes the results were marked by strong underwriting margins, lower than assumed share buybacks, and poor Japan and U.S. sales. The analyst, while keeping an Overweight rating on Aflac with a $47 price target, is less bullish following the stock's significant outperformance.
08/01/18
SDLR
08/01/18
UPGRADE
SDLR
Buy
Aflac upgraded to Buy from Hold at Sandler O'Neill
AGNC AGNC Investment
$18.80

-0.28 (-1.47%)

12/01/17
WELS
12/01/17
INITIATION
Target $19
WELS
Market Perform
AGNC Investment resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Donald Fandetti resumed coverage of AGNC Investment with a Market Perform rating and $19 price target.
02/01/18
BOFA
02/01/18
UPGRADE
BOFA
Neutral
AGNC Investment upgraded to Neutral from Underperform at BofA/Merrill
ALL Allstate
$98.78

0.38 (0.39%)

07/18/18
BUCK
07/18/18
UPGRADE
Target $88
BUCK
Neutral
Allstate upgraded to Neutral from Underperform at Buckingham
As previously reported, Buckingham upgraded Allstate to Neutral from Underperform. Analyst Amit Kumar raised his view citing valuation and maintained a $88 price target on shares.
07/18/18
BUCK
07/18/18
UPGRADE
BUCK
Neutral
Allstate upgraded to Neutral from Underperform at Buckingham
08/07/18
FBCO
08/07/18
INITIATION
Target $114
FBCO
Outperform
Allstate initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Zaremski started Allstate with an Outperform rating and $114 price target. The analyst believes Telematics is a profitability game changer, especially since Progressive (PGR) and Allstate have a huge lead on the competition. Zaremski thinks both companies are in the early innings of deploying their telematics data to improve their underwriting, claims, and marketing capabilities. Allstate has roughly 1M policyholders that are using its app or plug-in device, representing about 5% of its customer base, he notes, adding he expects this number to more than double in the coming 18 months, which will provide Allstate with enough data to extrapolate predictive analytics across its entire portfolio to price risk more accurately.
08/07/18
FBCO
08/07/18
INITIATION
Target $73
FBCO
Outperform
Progressive initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Zaremski started Progressive (PGR) with an Outperform rating and $73 price target. The analyst believes telematics has been and will continue to be a profitability game changer, and thinks Progressive, and to a lesser extent, Allstate (ALL), have huge leads on the competition, which he feels will afford them competitive advantages for years to come. Zaremski estimates Progressive has telematics data on approximately 25% of its customers, and expects this number to more than double in the coming 24 months, which will enable Progressive to further refine its underwriting factors to price risk more accurately and continue attracting the industry's best risks.
APO Apollo Global
$35.97

0.715 (2.03%)

07/24/18
FBCO
07/24/18
NO CHANGE
Target $65
FBCO
Neutral
LifePoint price target raised to $65 from $58 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for LifePoint (LPNT) to $65 from $58 to reflect deal price after the company agreed to be acquired by Apollo Global (APO) affiliates for $65 per share. The analyst reiterates a Neutral rating on LifePoint shares.
07/24/18
RBCM
07/24/18
DOWNGRADE
Target $65
RBCM
Sector Perform
LifePoint downgraded to Sector Perform at RBC Capital after Apollo acquisition
As reported earlier, RBC Capital analyst Frank Morgan downgraded LifePoint (LPNT) to Sector Perform from Outperform but raised his price target to $65 from $63 after the company's announced $65 per share acquisition by Apollo Global Management (APO). The analyst notes the deal is expected to close in the next few months.
07/23/18
GSCO
07/23/18
NO CHANGE
GSCO
Deal activity could pick up after LifePoint takeout, says Goldman Sachs
Goldman Sachs analyst Stephen Tanal said that although the hospital industry appears to be grappling with secular challenges, hospitals are still generating meaningful and relatively predictable cash flows and mostly trading at lower multiples than other stocks in the broader healthcare space. Given an environment in which rates are low, credit is available and financial buyers have "dry powder," he believes deal activity could pick up following LifePoint's (LPNT) agreement to be bought by Apollo Global (APO) affiliates. Community Health (CYH), like LifePoint, should be "relevant for years to come" as its hospitals are often the sole provider of acute healthcare services in small towns or rural areas, according to Tanal. HCA Healthcare (HCA), in contrast, is positioned in fast-growing markets with high levels of commercial coverage, Tanal added.
07/24/18
BMOC
07/24/18
NO CHANGE
Target $62
BMOC
Market Perform
LifePoint price target raised to $62 from $51 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on LifePoint (LPNT) to $62 and kept his Market Perform rating after the proposed transaction for the company to be taken private by the Apollo Global (APO) affiliate RCCH HealthCare Partners at $65 per share. The analyst says his price target reflects the acquisition price blended with some uncertainty regarding the deal, even as he views the terms of the offer as attractive to LifePoint shareholders against the"backdrop of reimbursement and volume pressures that challenge acute care hospitals".
BLK BlackRock
$487.42

4.42 (0.92%)

07/17/18
GSCO
07/17/18
NO CHANGE
Target $570
GSCO
Buy
BlackRock price target lowered to $570 from $605 at Goldman Sachs
Goldman Sachs analyst Alexander Blostein lowered his price target on BlackRock to $570 after its Q2 results, which highlighted a "challenging market backdrop" along with a deceleration in the company's organic fee growth to 4% from 7%. The analyst keeps his Buy rating on BlackRock however, stating that the slowdown in fees was likely "market driven" and does not reflect "company specific weaknesses", adding that BlackRock still has the "operating flexibility to deliver above trend operating income growth, while accelerating technology revenue growth". Blostein lowers his FY18 EPS forecast to $27.57 from $27.96 and FY19 to $30.81 from $31.64 to reflect lowers asset under management levels and lower ETF fee rates partially offset by stronger technology revenues and more accretion from stock buybacks.
07/02/18
JPMS
07/02/18
NO CHANGE
Target $547
JPMS
Overweight
BlackRock removed from Analyst Focus List at JPMorgan
JPMorgan analyst Kenneth Worthington removed BlackRock from his firm's Analyst Focus List and lowered his price target for the shares to $547 from $618. The analyst sees the macro environment as "less constructive" for BlackRock near term. Divergent beta trends have turned negative in recent months with both non-U.S. currencies and non-U.S. markets underperforming, Worthington tells investors in a research note. The analyst, however, continues to believe longer term secular trends are strong for iShares and keeps an Overweight rating on BlackRock.
07/13/18
07/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VF Corp. (VFC) upgraded two notches to Buy from Underperform at BofA/Merrill with analyst Robert Ohmes saying he believes Vans momentum is sustainable and will be a "go-to-brand" for the back-to-school selling season. 2. United Rentals (URI) and Herc Holdings (HRI) were upgraded to Buy from Neutral at Buckingham. 3. Raymond James (RJF) upgraded to Buy from Neutral at Citi with analyst William Katz saying he still prefers alternative managers. 4. M.D.C. Holdings (MDC) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018. 5. BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/18
KBWI
07/13/18
UPGRADE
KBWI
Outperform
BlackRock upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee upgraded BlackRock to Outperform saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. The analyst believes BlackRock will be able to sustain an organic growth rate over time in the mid-single-digit range, driving a premium valuation versus peers. Lee trimmed his price target on BlackRock to $590 from $617.
BBT BB&T
$51.72

0.29 (0.56%)

07/20/18
FIGP
07/20/18
DOWNGRADE
FIGP
Market Perform
BB&T downgraded to Market Perform from Outperform at Fig Partners
07/18/18
SPHN
07/18/18
NO CHANGE
Target $105
SPHN
Overweight
Comerica could be viewed as acquisition target, says Stephens
Stephens analyst Terry McEvoy raised his capital payout forecast for Comerica (CMA) for the second half of this year and for 2019 as he expects the company will announce an increase in the dividend and larger buyback plan after its board meets on July 24. Additionally, McEvoy thinks Comerica could be viewed as an takeover target once BB&T (BBT) and U.S. Bancorp (USB) are in a position to acquire banks. Stating that he likes both its fundamental and strategic outlook, McEvoy keeps an Overweight rating and $105 price target on Comerica shares.
04/11/18
EDJN
04/11/18
UPGRADE
EDJN
Buy
BB&T upgraded to Buy from Hold at Edward Jones
04/23/18
HDLY
04/23/18
UPGRADE
HDLY
Buy
BB&T upgraded to Buy from Neutral at Hilliard Lyons
BK BNY Mellon
$52.95

-0.09 (-0.17%)

03/12/18
GSCO
03/12/18
DOWNGRADE
Target $60
GSCO
Neutral
BNY Mellon downgraded to Neutral on valuation at Goldman Sachs
Goldman analyst Alexander Blostein downgraded BNY Mellon to Neutral from Buy citing valuation reflects near-term earnings growth and maintained a $60 price target.
03/07/18
BOFA
03/07/18
UPGRADE
BOFA
Neutral
BNY Mellon upgraded to Neutral from Underperform at BofA/Merrill
07/12/18
RAJA
07/12/18
DOWNGRADE
RAJA
Market Perform
BNY Mellon downgraded to Market Perform from Outperform at Raymond James
03/07/18
03/07/18
UPGRADE
Target $58

Neutral
BNY Mellon upgraded to Neutral on balanced risk/reward at BofA/Merrill
As previously reported, BofA/Merrill upgraded BNY Mellon to Neutral from Underperform and raised tis price target to $58 from $54. Analyst Michael Carrier expects this week's investor Day to be a positive event, highlighting growth initiatives, cost efficiencies and capital management. Carrier views risk/reward as more balanced saying business trends are decent, but some headwinds remain.
BAC Bank of America
$31.52

0.005 (0.02%)

04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
AXS Axis Capital
$54.48

-0.38 (-0.69%)

01/09/18
01/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Buy from Hold at Sandler O'Neill with analyst R. Scott Siefers saying he sees opportunity for Wells in cost control, capital management, and the valuation. 2. AXIS Capital (AXS) upgraded to Market Perform from Underperform at Wells Fargo with analyst Elyse Greenspan saying the current valuation limits the downside risk. 3. Sunoco (SUN) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Burd saying he estimates Sunoco will save $290M on its pending 7-Eleven sale tax bill versus prior expectation following the U.S. tax reform. 4. Ellie Mae (ELLI) upgraded to Overweight from Equal Weight at Barclays with analyst Saket Kalia saying mortgage volume processed by the company's platform will accelerate for the next two years. 5. PayPal (PYPL) upgraded to Outperform from Market Perform at Cowen with analyst George Mihalos saying he believes most of the bear worries, including margin compression, eBay (EBAY) renewal concerns, and a take-rate collapse, will not play out. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/18
WELS
01/09/18
UPGRADE
Target $52
WELS
Market Perform
AXIS Capital upgraded to Market Perform from Underperform at Wells Fargo
Wells Fargo analyst Elyse Greenspan upgraded AXIS Capital to Market Perform and lowered her price target for the shares to $52 from $54. The current valuation limits the downside risk, Greenspan tells investors in a research note. The analyst points out that the stock dropped 23% in 2017.
01/11/18
UBSW
01/11/18
UPGRADE
Target $52
UBSW
Neutral
Axis Capital upgraded to Neutral from Sell at UBS
UBS analyst Brian Meredith upgraded AXIS Capital to Neutral while lowering his price target for the shares to $52 from $55. The analyst believes the accretive Novae acquisition should drive improved return on equity. He sees a balanced risk/reward profile at current share levels.
06/18/18
GSCO
06/18/18
INITIATION
Target $60
GSCO
Neutral
Axis Capital initiated with a Neutral on execution risk at Goldman Sachs
Goldman Sachs analyst Yaron Knar initiated Axis Capital with a Neutral and $60 price target saying he sees execution risks from the turnaround initiative and Novae integration.
BX Blackstone
$35.56

0.28 (0.79%)

06/08/18
BUCK
06/08/18
NO CHANGE
Target $46
BUCK
Buy
Aspen Insurance exit value $48-$50 per share, says Buckingham
Buckingham analyst Amit Kumar says a 1.25 to 1.3 times multiple on Aspen Insurance's (AHL) current book value gives an exit value of $48-$50 per share. Insurance Insider published a story yesterday that noted the potential finalists in the Aspen bidding process are Blackstone (BX) and Apollo (APO), Kumar tells investors in a research note. He continues to be a buyer of the stock with a Buy rating and $46 price target.
07/10/18
MUFG
07/10/18
DOWNGRADE
Target $27.5
MUFG
Neutral
Gramercy Property Trust downgraded to Neutral from Overweight at MUFG
MUFG analyst Karin Ford downgraded Gramercy Property Trust (GPT) to Neutral with an unchanged price target of $27.50 citing the company's agreement to be acquired by Blackstone (BX).
05/22/18
BARD
05/22/18
DOWNGRADE
Target $34
BARD
Neutral
LaSalle Hotel downgraded to Neutral from Outperform at Baird
Baird analyst Michael Bellisario downgraded LaSalle Hotel (LHO) to Neutral following its buyout offer from Blackstone (BX). The agreement puts the shares at full valuation and essentially matches his buyout math. As a result, he believes a higher bid is unlikely. Bellisario raised his price target to $34 from $32 on LaSalle Hotel shares.
05/21/18
LEHM
05/21/18
UPGRADE
LEHM
Equal Weight
LaSalle Hotel upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Felicia Kantor Hendrix upgraded LaSalle Hotel (LHO) to Equal Weight from Underweight following the company's announcement that it has agreed to be acquired by Blackstone (BX).
CG Carlyle Group
$23.90

(0.00%)

03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/18
JEFF
02/14/18
UPGRADE
Target $27
JEFF
Buy
Carlyle Group upgraded to Buy from Hold at Jefferies
Jefferies analyst Gerald E. O'Hara upgraded Carlyle Group to Buy and raised his price target for the shares to $27 from $23. The analyst sees an attractive entry point for the shares with the company at the midway point of a $100B fundraising cycle. He believes Carlyle's net accrued performance fees are poised for continued growth with all main drawdown funds currently in carry contribution.
03/27/18
SBSH
03/27/18
NO CHANGE
SBSH
Citi says AkzoNobel free to think more strategically about M&A after divestiture
After AkzoNobel (AKZOY) announced the sale of its Specialty Chemicals business to Carlyle Group (CG) and GIC, Citi analyst P.J. Juvekar said the divestiture frees up the company to think more strategically about M&A. Akzo could go after Axalta (AXTA) again, but unless Akzo is prepared to pay a significant premium a deal is unlikely, said Juvekar. He thinks a price in the mid to high $30 range would be needed to get Axalta to the negotiating table. Akzo has thus far resisted a sale to PPG (PPG), but Juvekar thinks PPG would be interested if a deal were to be a friendly one.
03/12/18
SBSH
03/12/18
UPGRADE
Target $28.5
SBSH
Buy
Carlyle Group upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded Carlyle Group to Buy and raised his price target for the shares to $28.50 from $25. The analyst sees a higher FRE outlook and believes the recent pullback in shares enhances the risk adjusted return.
C Citi
$72.42

0.01 (0.01%)

07/27/18
RHCO
07/27/18
NO CHANGE
Target $240
RHCO
Buy
MasterCard price target raised to $240 from $215 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard to $240 and kept his Buy rating, saying the company is demonstrating expansion of global market share while posting a 14% Q2 volume growth. The analyst adds that while MasterCard has a higher valuation than PayPal (PYPL) and Visa (V) - a 10% relative EBITDA premium - it is justified and may even be too narrow given its superior growth sustainability and margin upside.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $85
BMOC
Market Perform
Citi price target raised to $85 from $76 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Citi to $85 after its Q2 earnings beat that was driven by better than expected investment banking and credit growth. The analyst also states that Citi's Q2 capital markets-related revenues were higher than expected, while the provisions for loan losses were lower than previously modeled. Fotheringham notes that Citi stock is "cheap again" following a 10% year-to-date decline, trading at only a 6.8-times two-year forward core earnings relative to its 9.5-times historical multiple.
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
06/29/18
OPCO
06/29/18
NO CHANGE
Target $88
OPCO
Outperform
Oppenheimer says 'particularly pleased' with Citi's $17.6B share buyback
Following the release of CCAR results for 2018, Oppenheimer analysts Chris Kotowski and Ben Chittenden told investors in a research note that they are "particularly pleased" with Citi's (C) $17.6B share buyback, up 13% from last year and above their $16.5B estimate, while the dividend increase to 45c was also 5c better than expected. The analysts noted that both Goldman (GS) and Morgan Stanley (MS) got "conditional passes" on their capital plans, as both banks "ran a bit afoul" of the supplementary leverage ratio limitation.
ETFC E-Trade
$61.08

0.68 (1.13%)

07/25/18
07/25/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VERTICAL GROUP RAISES SNAP RATING: Vertical Group analyst Phil Leggiere upgraded Snap (SNAP) to Mixed from Negative citing expectations for strong second half 2018 spending. Snap is higher by over 1% in late morning trading. PIVOTAL CUTS SPOTIFY TO HOLD: Pivotal Research analyst Jeffrey Wlodarczak downgraded Spotify (SPOT) to Hold from Buy with an unchanged price target of $200. The analyst cited valuation for the downgrade, given the "material rise" in the shares since his initiation report on May 29. Further, he increasingly views consensus 2018 premium monthly active user growth expectations as too aggressive. He lowered his Q2 premium subscriber MAU estimate from 6M to 5.5M, versus the consensus at 7M. Spotify's current valuation is fair and does not leave a lot of room for "operational/market hiccups," Wlodarczak told investors. DEUTSCHE SEES AMERITRADE/E-TRADE MERGER MAKING SENSE: Deutsche Bank analyst Brian Bedell continues to see a merger between TD Ameritrade (AMTD) and E-Trade (ETFC) as making strategic and financial sense. With TD Ameritrade's integration of recently acquired Scottrade progressing better than expectations, a merger scenario with E-Trade is "becoming more compelling," Bedell told investors. He updated his merger scenario model, raising his hypothetical merger scenario value of E-Trade from TD Ameritrade's perspective to $77 from $72, nearly a 30% premium to the current share price. Bedell raised his price target for TD Ameritrade to $77 from $72 and for E-Trade to $72 from $70. He kept Buy ratings on both stocks. GORDON HASKETT UPGRADES TARGET, DOWNGRADES WALMART: Gordon Haskett analyst Chuck Grom upgraded Target (TGT) to Accumulate from Hold and raised his price target on shares to $86 from 74 to reflect the recent acceleration in traffic. Grom said geolocation data and proprietary card data support his Q2 4.5% comp growth estimate. Grom also downgraded Walmart (WMT) to Hold from Accumulate and lowered its price target to $92 from $98. Grom thinks there are few near-term catalysts on the horizon and said the margin outlook is not as transparent following a period of improvement and stabilization. He expects Walmart shares to be range bound for the balance of the year.
06/04/18
COMP
06/04/18
INITIATION
Target $72
COMP
Buy
E-Trade initiated with a Buy at Compass Point
Compass Point initiated E-Trade with a Buy and $72 price target.
07/25/18
DBAB
07/25/18
NO CHANGE
Target $72
DBAB
Buy
Deutsche says Ameritrade, E-Trade merger 'becoming more compelling'
Deutsche Bank analyst Brian Bedell continues to see a merger between TD Ameritrade (AMTD) and E-Trade (ETFC) as making strategic and financial sense. With TD Ameritrade's integration of recently acquired Scottrade progressing better than expectations, a merger scenario with E-Trade is "becoming more compelling," Bedell tells investors in a research note. He updated his merger scenario model, raising his hypothetical merger scenario value of E-Trade from TD Ameritrade's perspective to $77 from $72, nearly a 30% premium to the current share price. Bedell raised his price target for TD Ameritrade to $77 from $72 and for E-Trade to $72 from $70. He keeps Buy ratings on both stocks.
07/20/18
FBCO
07/20/18
NO CHANGE
Target $77
FBCO
Outperform
E-Trade's softer growth may imply higher chance of takeout, says Credit Suisse
Credit Suisse analyst Craig Siegenthaler reiterated an Outperform rating on E-Trade (ETFC) and cut his price target to $77 from $79, telling investors in a research note that he forecasts modest upside to long-term EPS. The analyst says that softer core growth may imply a higher probability of a takeout, and thinks there is a ~50% probability that the board will look to sell the firm within six months. If E-Trade is put up for sale in October, the analyst estimates 30%+ upside given sizeable expense redundancies with likely acquirers TD Ameritrade (AMTD) and Charles Schwab (SCHW), but estimates ~10% near-term downside if the board decides to stay independent.
JPM JPMorgan
$117.54

0.44 (0.38%)

07/19/18
DZBN
07/19/18
UPGRADE
DZBN
Buy
JPMorgan upgraded to Buy from Hold at DZ Bank
07/16/18
BMOC
07/16/18
NO CHANGE
Target $118
BMOC
Market Perform
JPMorgan price target raised to $118 from $110 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $118 and kept his Market Perform rating after its Q2 results, saying the earnings beat consensus on higher than expected capital markets-related revenues. The analyst notes that equities trading was especially strong, while provisions for loan losses at JPMorgan were also lower than previously modeled.
MC Moelis
$59.20

-0.6 (-1.00%)

06/21/18
06/21/18
DOWNGRADE
Target $63

Equal Weight
Morgan Stanley downgrades Moelis to Equal Weight with valuation seen as full
As previously reported, Morgan Stanley analyst Betsy Graseck downgraded Moelis to Equal Weight from Overweight, noting that the stock's multiple has now hit its "high water mark" since the IPO four years ago. Revenue growth in Q1 was likely the peak for 2018 and Q2 will likely mark the low point of growth for the year, added Graseck, who keeps a $63 price target on the stock.
06/21/18
MSCO
06/21/18
DOWNGRADE
MSCO
Equal Weight
Moelis downgraded to Equal Weight from Overweight at Morgan Stanley
ICE IntercontinentalExchange
$73.71

1.14 (1.57%)

05/02/18
JPMS
05/02/18
NO CHANGE
Target $83
JPMS
Overweight
JPMorgan favors IntercontinentalExchange among exchange stocks
After a slow start to the year versus peers, IntercontinentalExchange activity levels in its core futures trading businesses have improved more recently, JPMorgan analyst Kenneth Worthington tells investors in a research note. He notes that while other exchanges are seeing a volumes decelerate from strong January and February levels, ICE is seeing much less deterioration and is now showing better year-over-year growth in April. The analyst favors IntercontinentalExchange among the exchange stocks and keeps an Overweight rating on the name with an $83 price target.
05/30/18
JPMS
05/30/18
NO CHANGE
Target $94
JPMS
Underweight
Cboe price target lowered to $94 from $102 at JPMorgan
JPMorgan analyst Kenneth Worthington lowered his price target for Cboe Global Markets (CBOE) to $94 and maintains an Underweight rating on the shares. Volumes remain weak, even on volatile days in the company's flagship VIX and SPX franchises, Worthington tells investors in a research note. The analyst sees more downside in CBOE shares "should velocity continue to normalize and weaker trading volumes persist." He continues to recommend shares of IntercontinentalExchange (ICE).
06/22/18
COMP
06/22/18
INITIATION
Target $85
COMP
Buy
IntercontinentalExchange initiated with a Buy at Compass Point
Compass Point initiated IntercontinentalExchange with a Buy and $85 price target.
07/09/18
WELS
07/09/18
NO CHANGE
Target $80
WELS
Market Perform
IntercontinentalExchange price target raised to $80 from $74 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for IntercontinentalExchange to $80 from $74 following the release of June and Q2 volume and rate per contract data. The analyst reiterates a Market Perform rating on the shares.
GS Goldman Sachs
$237.81

1.93 (0.82%)

07/18/18
OPCO
07/18/18
NO CHANGE
Target $335
OPCO
Outperform
Goldman Sachs price target raised to $335 from $304 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $335 from $304 following "excellent" results across businesses. The analyst reiterates an Outperform rating on the shares.
07/18/18
SOCG
07/18/18
UPGRADE
SOCG
Hold
Goldman Sachs upgraded to Hold from Sell at Societe Generale
07/17/18
07/17/18
UPGRADE
Target $280

Outperform
Credit Suisse upgrades Goldman Sachs to Outperform on higher earnings power
As previously reported, Credit Suisse analyst Susan Roth Katzke upgraded Goldman Sachs to Outperform from Neutral after the company's Q2 EPS of $5.98 came in well above the firm's estimate and the consensus view. The quarterly report evidenced progress against the bank's previously stated growth initiatives, the health of its "record" banking pipeline and the realization of its operating leverage, said the analyst, who has a $280 price target on the stock.
PRU Prudential
$100.35

0.7 (0.70%)

06/04/18
06/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Prudential (PRU) upgraded to Buy from Neutral at Goldman Sachs with analyst Alex Scott citing the company's "strong" cash flow and capital deployment yield for his upgrade. 2. Dollar General (DG) upgraded to Buy from Accumulate at Gordon Haskett. 3. AB InBev (BUD) upgraded to Buy from Hold at HSBC and Ambev (ABEV) upgraded to Hold from Reduce at HSBC. 4. Discovery (DISCA) and Nielsen (NLSN) were upgraded to Buy from Hold at Pivotal Research. 5. CSS Industries (CSS) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser saying he sees improving organic sales trends and an attractive free cash flow yield. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/06/18
MSCO
04/06/18
NO CHANGE
Target $128
MSCO
Equal Weight
Prudential poised to beat consensus Q1 expectations, says Morgan Stanley
Morgan Stanley analyst Nigel Dally thinks Prudential shares appear to be out of favor, but he sees the insurer as poised to beat consensus expectations in Q1 given favorable seasonality in both international and retirement. Dally has an Equal Weight rating and $128 price target on Prudential, which is schedule to report its Q1 results after the close on May 2.
06/04/18
GSCO
06/04/18
UPGRADE
GSCO
Buy
Prudential upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Alex Scott upgraded Prudential to Buy while lowering his price target for the shares to $117 from $122. The analyst cites the company's "strong" cash flow and capital deployment yield for his upgrade. He sees above average organic growth opportunities for Prudential, particularly in Retirement and Investment management.
04/25/18
FBCO
04/25/18
INITIATION
Target $102
FBCO
Neutral
Prudential initiated with a Neutral at Credit Suisse
Credit Suisse analyst Andrew Kligerman started Prudential with a Neutral rating and $102 price target as he believes its equity-sensitive, slow-growth business mix is fairly valued.
TRV Travelers
$129.94

-0.07 (-0.05%)

07/24/18
MKMP
07/24/18
NO CHANGE
Target $125
MKMP
Neutral
Travelers price target lowered to $125 from $140 at MKM Partners
MKM Partners analyst Harry Fong lowered his price target on Travelers to $125 after its Q2 earnings miss, saying the quarter was impacted by "several large commercial losses, chiefly from fire losses and an assessment from the Texas windstorm pool related to Hurricane Harvey". The analyst notes that the sell off in the stock was somewhat surprising, since the earnings miss was due to "normal insurance noise" that is typical for the industry. Fong also keeps his Neutral rating on Travelers which he attributes to 1.4-times trailing book value multiple, rather than its recent earnings proposal.
06/06/18
KBWI
06/06/18
NO CHANGE
KBWI
Amazon unlikely to overly disrupt insurance market, says Keefe Bruyette
Amazon.com's (AMZN) possible entry into homeowners insurance is unlikely to be "overly disruptive" to the industry, Keefe Bruyette analyst Meyer Shields told investors earlier in a research note. The analyst says that in the past, the U.S has been a relatively slow adopter of online insurance offerings. Names in the property and casualty insurance space include AIG (AIG), Allstate (ALL), Chubb (CB), Hartford Financial (HIG), Progressive (PGR) and Travelers (TRV).
07/12/18
SBSH
07/12/18
NO CHANGE
Target $144
SBSH
Buy
Citi opens 'Catalyst Watch' on Travelers ahead of earnings
Citi analyst James Naklicki opened a "Catalyst Watch on Travelers and is "tactically positive" on the stock into the quarterly earnings report. The analyst favors the Property and Casualty insurance brokers over the next 12-18 months saying U.S. commercial pricing is "modestly positive and will be a tailwind for organic growth this year." He lowered his price target for Travelers to $144 from $155 and keeps a Buy rating on the name.
08/07/18
FBCO
08/07/18
INITIATION
Target $141
FBCO
Neutral
Travelers initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Zaremski started Travelers (TRV) with a Neutral rating and $141 price target. For shorter-term oriented investors, the analyst recommends Travelers over peer Chubb (CB) due to having more conviction over its recent string of higher than expected non-catastrophe weather-related losses subsiding, a greater gearing to workers' comp. leading to a steady stream of reserve releases given an extremely healthy unemployment backdrop, and conviction that near-term auto margins will continue to improve given industry pricing dynamics. In the longer term, he struggles to make the case that Travelers' wheels business can produce better and less volatile results.
USB U.S. Bancorp
$53.30

0.38 (0.72%)

05/11/18
SBSH
05/11/18
UPGRADE
Target $58
SBSH
Buy
Citi upgrades U.S. Bancorp, says opportune time to build positions
Citi analyst Keith Horowitz upgraded U.S. Bancorp to Buy from Neutral with an unchanged price target of $58. Now is an opportune time to build positions in the stock after three years of significant underperformance, Horowitz tells investors in a research note. He believes the drivers of the underperformance have largely played out and that U.S. Bancorp's efficiency ratio will improve from here. Further, the bank's "strong" credit quality profile can be a differentiator as the cycle gets into the latter innings, Horowitz contends. He says U.S. Bancorp is one of the best ways for investors looking to add exposure to the banks.
05/11/18
05/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying after a meeting with CEO Lowell McAdam, he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." 2. Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Andrew Wong saying that it is "hard to ignore the improving undercurrents in both phosphate and potash markets." 3. Ultragenyx (RARE) upgraded to Overweight from Equal Weight at Barclays with analyst Gena Wang saying she thinks a higher price target for Crysvita could drive upside to revenue growth expectations. 4. U.S. Bancorp (USB) upgraded to Buy from Neutral at Citi with analyst Keith Horowitz saying now is an opportune time to build positions in the stock after three years of significant underperformance. 5. AMC Networks (AMCX) upgraded to Buy from Hold at Gabelli with the firm saying it remains an excelling company with opportunities to leverage its recent programming momentum into increased advertising and affiliate fees. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFC Wells Fargo
$58.83

-0.05 (-0.08%)

07/16/18
07/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term. 2. VF Corp. (VFC) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he sees an attractive risk/reward profile at current share levels given the company's "multi-year inflection." 3. UPS (UPS) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying the combination of cost and productivity improvements, coupled with a constructive" revenue backdrop, provide potential for improved Domestic Package margin performance and stronger operating income growth in 2019 for UPS. 4. Autoliv (ALV) upgraded to Outperform from Neutral at Daiwa. 5. Saratoga Investment (SAR) upgraded to Buy from Neutral at Compass Point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/15/18
KBWI
07/15/18
UPGRADE
Target $63
KBWI
Outperform
Wells Fargo upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded Wells Fargo to Outperform and raised his price target for the shares to $63 from $57. The stock closed Friday down 67c to $55.36. Current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term, Kleinhanzl tells investors in a research note. The analyst saw enough in Wells Fargo's most recent quarter to get him more constructive. He raised his earnings estimates and sees additional upside if management can drive expenses toward the company's investor day simulation range of $50B-$51B in 2020. Kleinhanzl sees expense saves and capital returns driving shares of Wells Fargo higher.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $61
BMOC
Market Perform
Wells Fargo price target raised to $61 at BMO Capital after in-line Q2
BMO Capital analyst James Fotheringham kept his Market Perform rating and nudged his price target on Wells Fargo (WFC) to $61 from $59 after the company's in-line Q2 "core" results which also showed higher than expected net interest margins and lower loss provisions. The analyst notes that after relative underperformance by the financials sector this year, he would recommend that investors buy "inexpensive stocks with near-term catalysts", including Santander (SC), OneMain (OMF), and Synchony (SYF).
WTFC Wintrust Financial
$89.14

-0.13 (-0.15%)

03/22/18
UBSW
03/22/18
INITIATION
Target $93
UBSW
Neutral
Wintrust Financial initiated with a Neutral at UBS
UBS analyst Brock Vandervliet started Wintrust Financial with a Neutral rating and $93 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
03/12/18
FIGP
03/12/18
DOWNGRADE
FIGP
Market Perform
Wintrust Financial downgraded to Market Perform from Outperform at Fig Partners
Fig Partners downgraded Wintrust Financial to Market Perform citing valuation.
02/09/18
FIGP
02/09/18
UPGRADE
FIGP
Outperform
Wintrust Financial upgraded to Outperform from Market Perform at Fig Partners
Fig Partners analyst John Rodis upgraded Wintrust Financial to Outperform saying the pullback in shares provides a buying opportunity.
01/24/18
DADA
01/24/18
NO CHANGE
Target $93
DADA
Neutral
Wintrust Financial price target raised to $93 from $84 at DA Davidson
DA Davidson analyst Kevin Reevey raised his price target on Wintrust Financial to $93 after Q4 earnings, saying the EPS decline from the past quarter was due to higher noninterest expenses that was partially offset by higher spread income. Reevey attributes the price target increase "mainly on lower effective corporate tax rate" expectations, while also keeping his Neutral rating on Wintrust Financial.

TODAY'S FREE FLY STORIES

WMT

Walmart

$97.89

-0.74 (-0.75%)

13:37
08/18/18
08/18
13:37
08/18/18
13:37
Periodicals
Walmart asks beauty suppliers to consider sourcing outside of China, Reuters say »

Walmart has asked some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

13:26
08/18/18
08/18
13:26
08/18/18
13:26
Periodicals
Tencent-backed Qutoutiao files for U.S. IPO, Reuters reports »

Chinese content…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

13:10
08/18/18
08/18
13:10
08/18/18
13:10
Periodicals
Selloff in Chinese internet stocks may shake faith in FANG, Reuters says »

A steep downturn in…

FB

Facebook

$173.78

-0.98 (-0.56%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

NFLX

Netflix

$316.78

-5.51 (-1.71%)

GOOG

Alphabet

$1,199.79

-6.21 (-0.51%)

GOOGL

Alphabet Class A

$1,215.50

-8.05 (-0.66%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

VLKAY

Volkswagen

$0.00

(0.00%)

13:05
08/18/18
08/18
13:05
08/18/18
13:05
Periodicals
Volkswagen CEO was told about emissions software months before, Reuters reports »

Volkswagen CEO Herbert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, TCEHY

Tencent

$0.00

(0.00%)

13:01
08/18/18
08/18
13:01
08/18/18
13:01
Hot Stocks
Walmart, Flipkart announce completion of investment »

Walmart (WMT) and…

WMT

Walmart

$97.89

-0.74 (-0.75%)

TCEHY

Tencent

$0.00

(0.00%)

MSFT

Microsoft

$107.58

-0.07 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

BBOX

Black Box

$1.64

0.09 (5.81%)

12:57
08/18/18
08/18
12:57
08/18/18
12:57
Hot Stocks
Black Box announces sale agreement of Federal Government IT Services Business »

Black Box announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$76.43

1.68 (2.25%)

12:52
08/18/18
08/18
12:52
08/18/18
12:52
Periodicals
Kohl's looking to break cycle, Barron's says »

Kohl's is set to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

STT

State Street

$84.95

0.73 (0.87%)

12:47
08/18/18
08/18
12:47
08/18/18
12:47
Periodicals
State Street selloff looks overdone, Barron's says »

At the moment, State…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

12:42
08/18/18
08/18
12:42
08/18/18
12:42
Periodicals
May be time to sell Walmart, Barron's says »

In a follow-up story,…

WMT

Walmart

$97.89

-0.74 (-0.75%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

VZ

Verizon

$54.79

0.51 (0.94%)

12:39
08/18/18
08/18
12:39
08/18/18
12:39
Periodicals
Verizon remains 'reasonably' priced, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CF

CF Industries

$47.52

0.25 (0.53%)

, MOS

Mosaic

$29.64

(0.00%)

12:36
08/18/18
08/18
12:36
08/18/18
12:36
Periodicals
CF, Mosaic gains have just begun, Barron's says »

CF Industries (CF),…

CF

CF Industries

$47.52

0.25 (0.53%)

MOS

Mosaic

$29.64

(0.00%)

NTR

Nutrien

$55.95

0.94 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 06

    Nov

ABBV

AbbVie

$98.79

0.6 (0.61%)

, LYB

LyondellBasell

$113.07

1.155 (1.03%)

12:25
08/18/18
08/18
12:25
08/18/18
12:25
Periodicals
StAbbVie, Starbucks among dividend standouts, Barron's says »

AbbVie (ABBV),…

ABBV

AbbVie

$98.79

0.6 (0.61%)

LYB

LyondellBasell

$113.07

1.155 (1.03%)

AVGO

Broadcom

$209.27

0.6 (0.29%)

RF

Regions Financial

$19.48

0.09 (0.46%)

SBUX

Starbucks

$53.58

0.53 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

BV

BrightView

$17.49

-0.06 (-0.34%)

12:21
08/18/18
08/18
12:21
08/18/18
12:21
Periodicals
Sunny outlook for BrightView, Barron's says »

BrightView's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

, CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

11:18
08/18/18
08/18
11:18
08/18/18
11:18
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

FSLR

First Solar

$50.98

0.18 (0.35%)

JASO

JA Solar

$0.00

(0.00%)

SUNEQ

SunEdison

$0.00

(0.00%)

SPWR

SunPower

$6.65

0.06 (0.91%)

TSL

Trina Solar

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:10
08/17/18
08/17
17:10
08/17/18
17:10
Hot Stocks
Boeing awarded $152.5M U.S. Navy contract »

Boeing is awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:09
08/17/18
08/17
17:09
08/17/18
17:09
Hot Stocks
Boeing awarded $217M Defense Department contract »

The Boeing Co has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$210.37

0.56 (0.27%)

17:08
08/17/18
08/17
17:08
08/17/18
17:08
Hot Stocks
L3 Technologies awarded $240M Defense Department contract »

L-3 Communications was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.65

-0.05 (-1.85%)

17:06
08/17/18
08/17
17:06
08/17/18
17:06
Syndicate
Breaking Syndicate news story on Histogenics »

Histogenics files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$67.45

1.79 (2.73%)

, DCT

DCT Industrial

$68.77

1.805 (2.70%)

16:58
08/17/18
08/17
16:58
08/17/18
16:58
Conference/Events
DCT Industrial to host special shareholder meeting »

Special Shareholder…

PLD

Prologis

$67.45

1.79 (2.73%)

DCT

DCT Industrial

$68.77

1.805 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.